最新报道:Solana-based biotech firm Artelo Biosciences has adopted SOL as a treasury asset, allocating $9.475 million to the cryptocurrency as part of its corporate treasury strategy. The NASDAQ-listed company aims to leverage Solana’s high-speed, low-cost blockchain for treasury management while maintaining traditional cash reserves. Artelo also announced a $2.5 million public offering to fund clinical trials for its cancer and metabolic disorder treatments. The move highlights growing institutional interest in blockchain-based treasury solutions.